Don Seiffert
Aug 19, 2015
Shares of Corbus Pharmaceuticals rose more than 50 percent today after the Norwood company announced that it got a designation from the FDA that could speed up the trial process for a drug to treat the “most lethal of the systemic autoimmune diseases,” according to the CEO.